Oral hypoglycemic agents for gestational diabetes mellitus?

Bibliography

• Kjos SL, Buchanan TA. Gestational diabetes mellitus. N Engl J Med 1999;341(23):1749-56
   PubMed Web of Science ®Google Scholar
• Metzger BE, Coustan DR. Summary and recommendations of the Fourth International Workshop-Conference on Gestational Diabetes Mellitus. The Organizing Committee. Diabetes Care 1998;21(Suppl 2):B161-67
   PubMed Web of Science ®Google Scholar
• Crowther CA, Hiller JE, Moss JR, Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N Engl J Med 2005;10(24):2477-86
   Web of Science ®Google Scholar
• Landon MB, Spong CY, Thom E, A multicenter, randomized trial of treatment for mild gestational diabetes. N Engl J Med 2009;361(14):1339-48
   PubMed Web of Science ®Google Scholar
• Langer O, Conway DL, Berkus MD, A comparison of glyburide and insulin in women with gestational diabetes mellitus. N Engl J Med 2000;343(16):1134-8
   PubMed Web of Science ®Google Scholar
• Langer O, Yogev Y, Most O, Xenakis EM. Gestational diabetes: the consequences of not treating. Am J Obstet Gynecol 2005;192(4):989-97
   PubMed Web of Science ®Google Scholar
• Rowan JA, Hague WM, Gao W, Metformin versus insulin for the treatment of gestational diabetes. N Engl J Med 2008;358(19):2003-15
   PubMed Web of Science ®Google Scholar
• Kim C, Newton KM, Knopp RH. Gestational diabetes and the incidence of type 2 diabetes: a systematic review. Diabetes Care 2002;25(10):1862-8
   PubMed Web of Science ®Google Scholar
• Feig DS, Zinman B, Wang X, Hux JE. Risk of development of diabetes mellitus after diagnosis of gestational diabetes. CMAJ 2008;179(3):229-34
   PubMed Web of Science ®Google Scholar
• Retnakaran R. Glucose tolerance status in pregnancy: a window to the future risk of diabetes and cardiovascular disease in young women. Curr Diabetes Rev 2009;5(4):239-44
   PubMedGoogle Scholar
• Boney CM, Verma A, Tucker R, Vohr BR. Metabolic syndrome in childhood: association with birth weight, maternal obesity, and gestational diabetes mellitus. Pediatrics 2005;115(3):E290-6
   PubMed Web of Science ®Google Scholar
• Keely EJ, Malcolm JC, Hadjiyannakis S, Prevalence of metabolic markers of insulin resistance in offspring of gestational diabetes pregnancies. Pediatr Diabetes 2008;9(1):53-9
   PubMed Web of Science ®Google Scholar
• Pirkola J, Pouta A, Bloigu A, Risks of overweight and abdominal obesity at age 16 years associated with prenatal exposures to maternal prepregnancy overweight and gestational diabetes mellitus. Diabetes Care 2010;33(5):1115-21
   PubMed Web of Science ®Google Scholar
• Gillman MW, Oakey H, Baghurst PA, Effect of treatment of gestational diabetes mellitus on obesity in the next generation. Diabetes Care 2010;33(5):964-8
   PubMed Web of Science ®Google Scholar
• Clausen TD, Mathiesen ER, Hansen T, High prevalence of type 2 diabetes and pre-diabetes in adult offspring of women with gestational diabetes mellitus or type 1 diabetes: the role of intrauterine hyperglycemia. Diabetes Care 2008;31(2):340-6
   PubMed Web of Science ®Google Scholar
• Clausen TD, Mathiesen ER, Hansen T, Overweight and the metabolic syndrome in adult offspring of women with diet-treated gestational diabetes mellitus or type 1 diabetes. J Clin Endocrinol Metab 2009;94(7):2464-70
   PubMed Web of Science ®Google Scholar
• Lindsay RS. Gestational diabetes: causes and consequences. Br J Diabetes Vascu Dis 2009;9(1):27-31
   Google Scholar
• Hillier TA, Pedula KL, Schmidt MM, Childhood obesity and metabolic imprinting: the ongoing effects of maternal hyperglycemia. Diabetes Care 2007;30(9):2287-92
   PubMed Web of Science ®Google Scholar
• American Diabetes Association. Gestational diabetes mellitus. Diabetes Care 2004;27(Suppl 1):S88-90
   PubMed Web of Science ®Google Scholar
• Dabelea D, Snell-Bergeon JK, Hartsfield CL, Increasing prevalence of gestational diabetes mellitus (GDM) over time and by birth cohort: Kaiser Permanente of Colorado GDM Screening Program. Diabetes Care 2005;28(3):579-84
   PubMed Web of Science ®Google Scholar
• Canadian Diabetes Association Clinical Practice Guidelines Expert Committee. Canadian Diabetes Association 2008 clinical practice guidelines for the prevention and management of diabetes in Canada. Can J Diabetes 2008;32(Suppl 1):S1-S201
   Google Scholar
• American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2008;31(Suppl 1):S55-60
   PubMed Web of Science ®Google Scholar
• Ma RC, Chan JC. Pregnancy and diabetes scenario around the world: China. Int J Gynaecol Obstet 2009;104(Suppl 1):S42-5
   PubMed Web of Science ®Google Scholar
• Seshiah V, Balaji V, Balaji MS, Pregnancy and diabetes scenario around the world: India. Int J Gynaecol Obstet 2009;104(Suppl 1):S35-8
   PubMed Web of Science ®Google Scholar
• Chen Y, Quick WW, Yang W, Cost of gestational diabetes mellitus in the United States in 2007. Popul Health Manag 2009;12(3):165-74
   PubMed Web of Science ®Google Scholar
• Rai L, Meenakshi D, Kamath A. Metformin – a convenient alternative to insulin for Indian women with diabetes in pregnancy. Indian J Med Sci 2009;63(11):491-7
   PubMedGoogle Scholar
• Coetzee EJ, Jackson WP. The management of non-insulin-dependent diabetes during pregnancy. Diabetes Res Clin Pract 1985;1(5):281-7
   PubMedGoogle Scholar
• Harlev A, Wiznitzer A. New insights on glucose pathophysiology in gestational diabetes and insulin resistance. Curr Diab Rep 2010;10(3):242-7
   PubMed Web of Science ®Google Scholar
• American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2010;33(Suppl 1):S62-9
   PubMed Web of Science ®Google Scholar
• Butte NF. Carbohydrate and lipid metabolism in pregnancy: normal compared with gestational diabetes mellitus. Am J Clin Nutr 2000;71(5):1256S-12561S
   PubMed Web of Science ®Google Scholar
• Catalano PM, Tyzbir ED, Wolfe RR, Carbohydrate metabolism during pregnancy in control subjects and women with gestational diabetes. Am J Physiol 1993;264(1 Pt 1):E60-7
   PubMed Web of Science ®Google Scholar
• Elliott BD, Schenker S, Langer O, Comparative placental transport of oral hypoglycemic agents in humans: a model of human placental drug transfer. Am J Obstet Gynecol 1994;171(3):653-60
   PubMed Web of Science ®Google Scholar
• Gedeon C, Koren G. Designing pregnancy centered medications: drugs which do not cross the human placenta. Placenta 2006;27(8):861-8
   PubMed Web of Science ®Google Scholar
• Hemauer SJ, Patrikeeva SL, Nanovskaya TN, Role of human placental apical membrane transporters in the efflux of glyburide, rosiglitazone, and metformin. Am J Obstet Gynecol 2010;202(4):383-7
   PubMed Web of Science ®Google Scholar
• Langer O, Yogev Y, Xenakis EM, Rosenn B. Insulin and glyburide therapy: dosage, severity level of gestational diabetes, and pregnancy outcome. Am J Obstet Gynecol 2005;192(1):134-9
   PubMed Web of Science ®Google Scholar
• Hebert MF, Ma X, Naraharisetti SB, Are we optimizing gestational diabetes treatment with glyburide? The pharmacologic basis for better clinical practice. Clin Pharmacol Ther 2009;85(6):607-14
   PubMed Web of Science ®Google Scholar
• Chmait R, Dinise T, Moore T. Prospective observational study to establish predictors of glyburide success in women with gestational diabetes mellitus. J Perinatol 2004;24(10):617-22
   PubMedGoogle Scholar
• Conway DL, Gonzales O, Skiver D. Use of glyburide for the treatment of gestational diabetes: the San Antonio experience. J Matern Fetal Neonatal Med 2004;15(1):51-5
   PubMedGoogle Scholar
• Holt RI, Clarke P, Parry EC, Coleman MA. The effectiveness of glibenclamide in women with gestational diabetes. Diabetes Obes Metab 2008;10(10):906-11
   PubMed Web of Science ®Google Scholar
• Jacobson GF, Ramos GA, Ching JY, Comparison of glyburide and insulin for the management of gestational diabetes in a large managed care organization. Am J Obstet Gynecol 2005;193(1):118-24
   PubMed Web of Science ®Google Scholar
• Kahn BF, Davies JK, Lynch AM, Predictors of glyburide failure in the treatment of gestational diabetes. Obstet Gynecol 2006;107(6):1303-9
   PubMed Web of Science ®Google Scholar
• Kremer CJ, Duff P. Glyburide for the treatment of gestational diabetes. Am J Obstet Gynecol 2004;190(5):1438-9
   PubMed Web of Science ®Google Scholar
• Lim JM, Tayob Y, O'Brien PM, Shaw RW. A comparison between the pregnancy outcome of women with gestation diabetes treated with glibenclamide and those treated with insulin. Med J Malaysia 1997;52(4):377-81
   PubMedGoogle Scholar
• Ramos GA, Jacobson GF, Kirby RS, Comparison of glyburide and insulin for the management of gestational diabetics with markedly elevated oral glucose challenge test and fasting hyperglycemia. J Perinatol 2007;27(5):262-7
   PubMed Web of Science ®Google Scholar
• Silva JC, Bertini AM, Taborda W, Glibenclamide in the treatment for gestational diabetes mellitus in a compared study to insulin. Arq Bras Endocrinol Metabol 2007;51(4):541-6
   PubMed Web of Science ®Google Scholar
• Yogev Y, Ben Haroush A, Chen R, Undiagnosed asymptomatic hypoglycemia: diet, insulin, and glyburide for gestational diabetic pregnancy. Obstet Gynecol 2004;104(1):88-93
   PubMed Web of Science ®Google Scholar
• Ogunyemi D, Jesse M, Davidson M. Comparison of glyburide versus insulin in management of gestational diabetes mellitus. Endocr Pract 2007;13(4):427-8
   PubMedGoogle Scholar
• Anjalakshi C, Balaji V, Balaji MS, Seshiah V. A prospective study comparing insulin and glibenclamide in gestational diabetes mellitus in Asian Indian women. Diabetes Res Clin Pract 2007;76(3):474-5
   PubMed Web of Science ®Google Scholar
• Moretti ME, Rezvani M, Koren G. Safety of glyburide for gestational diabetes: a meta-analysis of pregnancy outcomes. Ann Pharmacother 2008;42(4):483-90
   PubMed Web of Science ®Google Scholar
• Charles B, Norris R, Xiao X, Hague W. Population pharmacokinetics of metformin in late pregnancy. Ther Drug Monit 2006;28(1):67-72
   PubMed Web of Science ®Google Scholar
• Nanovskaya TN, Nekhayeva IA, Patrikeeva SL, Transfer of metformin across the dually perfused human placental lobule. Am J Obstet Gynecol 2006;195(4):1081-5
   PubMed Web of Science ®Google Scholar
• Elliott BD, Langer O, Schuessling F. Human placental glucose uptake and transport are not altered by the oral antihyperglycemic agent metformin. Am J Obstet Gynecol 1997;176(3):527-30
   PubMed Web of Science ®Google Scholar
• Vanky E, Zahlsen K, Spigset O, Carlsen SM. Placental passage of metformin in women with polycystic ovary syndrome. Fertil Steril 2005;83(5):1575-8
   PubMed Web of Science ®Google Scholar
• Moore LE, Briery CM, Clokey D, Metformin and insulin in the management of gestational diabetes mellitus: preliminary results of a comparison. J Reprod Med 2007;52(11):1011-15
   PubMed Web of Science ®Google Scholar
• Baillargeon JP, Jakubowicz DJ, Iuorno MJ, Effects of metformin and rosiglitazone, alone and in combination, in nonobese women with polycystic ovary syndrome and normal indices of insulin sensitivity. Fertil Steril 2004;82(4):893-902
   PubMed Web of Science ®Google Scholar
• Gagnon C, Baillargeon JP. Suitability of recommended limits for fasting glucose tests in women with polycystic ovary syndrome. CMAJ 2007;176(7):933-8
   PubMed Web of Science ®Google Scholar
• Genazzani AD, Ricchieri F, Lanzoni C. Use of metformin in the treatment of polycystic ovary syndrome. Womens Health (Lond Engl) 2010;6(4):577-93
   PubMedGoogle Scholar
• Bolton S, Cleary B, Walsh J, Continuation of metformin in the first trimester of women with polycystic ovarian syndrome is not associated with increased perinatal morbidity. Eur J Pediatr 2009;168(2):203-6
   PubMed Web of Science ®Google Scholar
• Gilbert C, Valois M, Koren G. Pregnancy outcome after first-trimester exposure to metformin: a meta-analysis. Fertil Steril 2006;86(3):658-63
   PubMed Web of Science ®Google Scholar
• Glueck CJ, Bornovali S, Pranikoff J, Metformin, pre-eclampsia, and pregnancy outcomes in women with polycystic ovary syndrome. Diabet Med 2004;21(8):829-36
   PubMed Web of Science ®Google Scholar
• Salvesen KA, Vanky E, Carlsen SM. Metformin treatment in pregnant women with polycystic ovary syndrome – is reduced complication rate mediated by changes in the uteroplacental circulation? Ultrasound Obstet Gynecol 2007;29(4):433-7
   PubMed Web of Science ®Google Scholar
• Glueck CJ, Phillips H, Cameron D, Continuing metformin throughout pregnancy in women with polycystic ovary syndrome appears to safely reduce first-trimester spontaneous abortion: a pilot study. Fertil Steril 2001;75(1):46-52
   PubMed Web of Science ®Google Scholar
• Glueck CJ, Wang P, Kobayashi S, Metformin therapy throughout pregnancy reduces the development of gestational diabetes in women with polycystic ovary syndrome. Fertil Steril 2002;77(3):520-5
   PubMed Web of Science ®Google Scholar
• Glueck CJ, Pranikoff J, Aregawi D, Wang P. Prevention of gestational diabetes by metformin plus diet in patients with polycystic ovary syndrome. Fertil Steril 2008;89(3):625-34
   PubMed Web of Science ®Google Scholar
• Glueck CJ, Goldenberg N, Pranikoff J, Height, weight, and motor-social development during the first 18 months of life in 126 infants born to 109 mothers with polycystic ovary syndrome who conceived on and continued metformin through pregnancy. Hum Reprod 2004;19(6):1323-30
   PubMed Web of Science ®Google Scholar
• Moore LE, Clokey D, Rappaport VJ, Curet LB. Metformin compared with glyburide in gestational diabetes: a randomized controlled trial. Obstet Gynecol 2010;115(1):55-9
   PubMed Web of Science ®Google Scholar
• Silva JC, Pacheco C, Bizato J, Metformin compared with glyburide for the management of gestational diabetes. Int J Gynaecol Obstet 2010: published online 12 June 2010, doi:10.1016/j.ijgo.2010.04.028
   Google Scholar
• Gutzin SJ, Kozer E, Magee LA, The safety of oral hypoglycemic agents in the first trimester of pregnancy: a meta-analysis. Can J Clin Pharmacol 2003;10(4):179-83
   PubMedGoogle Scholar
• Nicholson W, Bolen S, Witkop CT, Benefits and risks of oral diabetes agents compared with insulin in women with gestational diabetes: a systematic review. Obstet Gynecol 2009;113(1):193-205
   PubMed Web of Science ®Google Scholar
• Vanky E, Salvesen KA, Heimstad R, Metformin reduces pregnancy complications without affecting androgen levels in pregnant polycystic ovary syndrome women: results of a randomized study. Hum Reprod 2004;19(8):1734-40
   PubMed Web of Science ®Google Scholar
• Bertini AM, Silva JC, Taborda W, Perinatal outcomes and the use of oral hypoglycemic agents. J Perinat Med 2005;33(6):519-23
   PubMed Web of Science ®Google Scholar
• Lain KY, Garabedian MJ, Daftary A, Jeyabalan A. Neonatal adiposity following maternal treatment of gestational diabetes with glyburide compared with insulin. Am J Obstet Gynecol 2009;200(5):501-6
   PubMed Web of Science ®Google Scholar
• Canadian Pharmacists Association. Compendium of Pharmaceuticals and Specialities. Ottawa; 2010
   Google Scholar
• Glucophage. FDA Approved Drug Products. Silver Spring, MD: FDA/Center for Drug Evaluation and Research, 2008. Available from: www.accessdata.fda.gov/drugsatfda_docs/label/2008/020357s031,021202s016lbl.pdf [Last accessed 14 July 2010]
   Google Scholar
• Diabeta. FDA Approved Drug Products. Silver Spring, MD: FDA/Center for Drug Evaluation and Research, 2008. Available from: www.accessdata.fda.gov/drugsatfda_docs/label/2009/017532s030lbl.pdf [Last accessed 14 July 2010]
   Google Scholar
• Meadows M. Pregnancy and the drug dilemma. FDA Consum 2001;35(3):16-20
   PubMedGoogle Scholar
• Schwarz EB, Postlethwaite DA, Hung YY, Armstrong MA. Documentation of contraception and pregnancy when prescribing potentially teratogenic medications for reproductive-age women. Ann Intern Med 2007;147(6):370-6
   PubMed Web of Science ®Google Scholar
• Fisher B, Rose NC, Carey JC. Principles and practice of teratology for the obstetrician. Clin Obstet Gynecol 2008;51(1):106-18
   PubMed Web of Science ®Google Scholar
• Allen VM, Armson BA, Wilson RD, Teratogenicity associated with pre-existing and gestational diabetes. J Obstet Gynaecol Can 2007;29(11):927-44
   PubMedGoogle Scholar
• Eriksson UJ, Cederberg J, Wentzel P. Congenital malformations in offspring of diabetic mothers – animal and human studies. Rev Endocr Metab Disord 2003;4(1):79-93
   PubMed Web of Science ®Google Scholar
• Garcia-Patterson A, Erdozain L, Ginovart G, In human gestational diabetes mellitus congenital malformations are related to pre-pregnancy body mass index and to severity of diabetes. Diabetologia 2004;47(3):509-14
   PubMed Web of Science ®Google Scholar
• Correa A, Gilboa SM, Besser LM, Diabetes mellitus and birth defects. Am J Obstet Gynecol 2008;199: 237.e1-237.e9
   Web of Science ®Google Scholar
• Eyal S, Easterling TR, Carr D, Pharmacokinetics of metformin during pregnancy. Drug Metab Dispos 2010;38(5):833-40
   PubMed Web of Science ®Google Scholar
• Pollex EK, Feig DS, Koren G. Oral hypoglycemic therapy: understanding the mechanisms of transplacental transfer. J Matern Fetal Neonatal Med 2010;23(3):224-8
   PubMed Web of Science ®Google Scholar
• Feig DS. Metformin therapy for gestational diabetes mellitus: are we there yet? Nat Clin Pract Endocrinol Metab 2008;4(12):654-5
   PubMedGoogle Scholar
• Rochon M, Rand L, Roth L, Gaddipati S. Glyburide for the management of gestational diabetes: risk factors predictive of failure and associated pregnancy outcomes. Am J Obstet Gynecol 2006;195(4):1090-4
   PubMed Web of Science ®Google Scholar
• Hebert MF, Easterling TR, Kirby B, Effects of pregnancy on CYP3A and P-glycoprotein activities as measured by disposition of midazolam and digoxin: a University of Washington specialized center of research study. Clin Pharmacol Ther 2008;84(2):248-53
   PubMed Web of Science ®Google Scholar
• Zhou L, Naraharisetti SB, Liu L, Contributions of human cytochrome P450 enzymes to glyburide metabolism. Biopharm Drug Dispos 2010;31(4):228-42
   PubMed Web of Science ®Google Scholar
• Glucovance. ClinicalTrials.gov. Bethesda, MD: National Institutes of Health, 2010. Available from: www.clinicaltrials.gov/ct2/show/NCT00371306
   Google Scholar
• Douglas CP, Richards R. Use of chlorpropamide in the treatment of diabetes in pregnancy. Diabetes 1967;16(1):60-1
   PubMed Web of Science ®Google Scholar
• Larsson Y, Sterky G. Possible teratogenic effect of tolbutamide in a pregnant prediabetic. Lancet 1960;276(7166):1424-5
   Google Scholar
• McElduff A, Cheung NW, McIntyre HD, The Australasian diabetes in pregnancy society consensus guidelines for the management of type 1 and type 2 diabetes in relation to pregnancy. Med J Aust 2005;183(7):373-7
   PubMed Web of Science ®Google Scholar
• Diabetes in pregnancy: management of diabetes and its complications from preconception to the postnatal period. NICE clinical guideline 63. National Collaborating Centre for Women's and Children's Health. London: National Institute for Health and Clinical Excellence, 2008. Available from: www.nice.org.uk/nicemedia/pdf/cg063guidance.pdf [Last accessed 14 July 2010]
   Google Scholar
• Simmons D, Walters BN, Rowan JA, McIntyre HD. Metformin therapy and diabetes in pregnancy. Med J Aust 2004;180(9):462-4
   PubMed Web of Science ®Google Scholar
• Types of Diabetes. WHO Diabetes Action Online. Geneva: World Health Organization, 2010. Available from: www.who.int/diabetesactiononline/diabetes/basics/en/index1.html [Last accessed 14 July 2010]
   Google Scholar
• Gabbe SG, Gregory RP, Power ML, Management of diabetes mellitus by obstetrician-gynecologists. Obstet Gynecol 2004;103(6):1229-34
   PubMed Web of Science ®Google Scholar
• Koren G. Breakthrough in treating gestational diabetes mellitus. Can Fam Physician 2004;50:987-9
   PubMed Web of Science ®Google Scholar
• Petrak F, Stridde E, Leverkus F, Development and validation of a new measure to evaluate psychological resistance to insulin treatment. Diabetes Care 2007;30(9):2199-204
   PubMed Web of Science ®Google Scholar
• Global Guideline on Pregnancy and Diabetes. IDF Clinical Guidelines Task Force. Brussels: International Diabetes Federation, 2009. Available from: www.idf.org/webdata/docs/Pregnancy_EN_RTP.pdf [Last accessed 14 July 2010]
   Google Scholar
• Dupont F, Gagnon R, Auray-Blais C, Ardilouze JL. Toward a new marker assessing fetal metabolic programming: the fetal glycated hemoglobin [abstract 0122-LB]. Diabetes 2010;59(Suppl 1A):LB33
   Google Scholar